Catalyst Wire Dossier Catalyst Wire Dossier

Olmutinib

olmutinib · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Olmutinib, covering 2016-07-13 to 2019-08-28. Get the full timeline:

Most recent: Clinical Trial Update: Olmutinib Trial in T790M (+) NSCLC Patients Detected by Liquid Biopsy Using BALF Extracellular Vesicular DNA [Phase 2]

See pricing